Insights and examples of how collaborative efforts can lead to the development of innovative therapies that target unmet patient needs.
Bertrand Ducrey
Advertisement
Bertrand Ducrey, Ph.D., is the CEO of Debiopharm, a Swiss-based global biopharmaceutical company.
Articles by Bertrand Ducrey
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer
2
AI has Redefined Healthcare Communication — and There’s No Opting Out
3
How FDA's Removal of the Two-Trial Requirement Affects Development Programs
4
Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals
5